News
News
- Decibel Therapeutics Presents Promising Preclinical Findings on DB-OTO, Gene Therapy Product Candidate Designed to Provide Hearing to Individuals with Otoferlin Mutations
13:00 - GlobeNewswire - AC Immune to Present New Data from Alpha-Synuclein and TDP-43 Programs at the AD/PD™ 2021 Virtual Conference
13:00 - GlobeNewswire - Hydrofarm Holdings Group Releases Growth Outlook for Fiscal 2021 as Controlled Environment Agriculture Market Continues to Expand
13:00 - GlobeNewswire - Constellation Pharmaceuticals Announces Fourth-Quarter and Full-Year 2020 Financial Results
13:00 - GlobeNewswire - ORBCOMM Announces Fourth Quarter and Full Year 2020 Results
13:00 - GlobeNewswire - Kura Oncology Receives FDA Breakthrough Therapy Designation for Tipifarnib in Head and Neck Squamous Cell Carcinoma
13:00 - GlobeNewswire - Cybrexa Therapeutics Enters Cooperative Research and Development Agreement (CRADA) with U.S. National Cancer Institute to Develop CBX-12 (alphalex™- exatecan)
13:00 - GlobeNewswire - Kamada Files Annual Report for the Year Ended December 31, 2020
13:00 - GlobeNewswire - Butterfly Protocol Launches Sponsored Top-Level Domains
13:00 - GlobeNewswire - Teleflex Announces Submission of Biologics License Application for Its Investigational Freeze Dried Plasma
12:30 - GlobeNewswire
Real-time